Long-term hypervitaminosis D-induced hypercalcaemia treated with glucocorticoids and bisphosphonates

被引:3
作者
Houghton, Chase C. [1 ]
Lew, Susie Q. [1 ]
机构
[1] George Washington Univ, Med, Washington, DC 20052 USA
关键词
vitamins and supplements; calcium and bone; fluid electrolyte and acid-base disturbances; VITAMIN-D DEFICIENCY; CALCIUM-METABOLISM; MANAGEMENT; MALIGNANCY; CALCITONIN; DENOSUMAB; DIAGNOSIS;
D O I
10.1136/bcr-2019-233853
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypercalcaemia is a common diagnosis with the majority of cases resulting from hyperparathyroidism or malignancy. We report a rare case of persistent symptomatic hypervitaminosis D-induced hypercalcaemia in an individual taking 50000 IU of vitamin D supplement daily for several months following a diagnosis of vitamin D deficiency. His hypercalcaemia was initially treated with calcitonin and intravenous fluids, but due to recurrent symptomatic hypercalcaemia after discharge, additional treatment with glucocorticoids and bisphosphonates was warranted during his second admission. The pathophysiology of hypercalcaemia from vitamin D intoxication results from the long-term effects of vitamin D storage in adipose tissue. In the present case, we discuss this pathophysiology and treatment approaches in the context of increasing awareness of and testing for vitamin D deficiency, and growing access to over-the-counter supplements.
引用
收藏
页数:4
相关论文
共 21 条
[1]   Denosumab in hypercalcemia of malignancy: A case series [J].
Dietzek, Amanda ;
Connelly, Kelly ;
Cotugno, Michael ;
Bartel, Sylvia ;
McDonnell, Anne M. .
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2015, 21 (02) :143-147
[2]   Vitamin D deficiency [J].
Holick, Michael F. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (03) :266-281
[3]   Influence of Vitamin D Status and Vitamin D3 Supplementation on Genome Wide Expression of White Blood Cells: A Randomized Double-Blind Clinical Trial [J].
Hossein-nezhad, Arash ;
Spira, Avrum ;
Holick, Michael F. .
PLOS ONE, 2013, 8 (03)
[4]   Denosumab for Treatment of Hypercalcemia of Malignancy [J].
Hu, Mimi I. ;
Glezerman, Ilya G. ;
Leboulleux, Sophie ;
Insogna, Karl ;
Gucalp, Rasim ;
Misiorowski, Waldemar ;
Yu, Bennett ;
Zorsky, Paul ;
Tosi, Diego ;
Bessudo, Alberto ;
Jaccard, Arnaud ;
Tonini, Giuseppe ;
Ying, Wendy ;
Braun, Ada ;
Jain, Rajul K. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (09) :3144-3152
[5]   CLINICAL REVIEW: Rare causes of hypercalcemia [J].
Jacobs, TP ;
Bilezikian, JP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (11) :6316-6322
[6]   Pharmacokinetics of vitamin D toxicity [J].
Jones, Glenville .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2008, 88 (02) :582S-586S
[7]   EFFECT OF PORCINE CALCITONIN ON HYPERCALCEMIA IN MAN [J].
KAMMERMAN, S ;
CANFIELD, RE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1970, 31 (01) :70-+
[8]  
LAFFERTY F W, 1991, Journal of Bone and Mineral Research, V6, pS51
[9]   Screening for Vitamin D Deficiency: A Systematic Review for the US Preventive Services Task Force [J].
LeBlanc, Erin S. ;
Zakher, Bernadette ;
Daeges, Monica ;
Pappas, Miranda ;
Chou, Roger .
ANNALS OF INTERNAL MEDICINE, 2015, 162 (02) :109-+
[10]  
LeFevre ML, 2015, ANN INTERN MED, V162, P133, DOI 10.7326/M14-2450